Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04637087 · ClinicalTrials.gov registry record · NA
Precision Medicine in Ischemic Stroke and Atrial Fibrillation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 805
- Enrollment target
NCT04637087: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04637087 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 805 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04637087, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 805 participants
- Enrollment target
Study Summary
The overall goal of this study is to minimize morbidity due to Atrial Fibrillation (AF). The specific objective is to develop and implement a rational and personalized approach to AF risk estimation that can inform management decisions with ischemic stroke. The investigators propose to develop a clinical AF risk estimation tool in the electronic health record and to test the effectiveness of implementing a clinical AF risk estimation tool into care for use by stroke neurologists during the care of acute ischemic stroke patients at Massachusetts General Hospital. The investigators will evaluate cardiac monitoring utilization calibrated to AF risk by stroke neurologists using a custom electronic health record (EHR) notification module. The investigators hypothesize that cardiac rhythm monitoring utilization will be positively correlated with the predicted risk of AF.
Interventions
- OTHER Atrial fibrillation risk electronic health record alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 805 participants |
| Start Date | 2021-03-11 |
| Est. Completion | 2024-07-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04637087
The ClinicalTrials.gov registry entry for NCT04637087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 805 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atrial fibrillation risk electronic health record alert is the first listed.
NCT04637087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04637087 about?
NCT04637087 is a clinical study titled "Precision Medicine in Ischemic Stroke and Atrial Fibrillation". The overall goal of this study is to minimize morbidity due to Atrial Fibrillation (AF). The specific objective is to develop and implement a rational and personalized approach to AF risk estimation that can inform management decisions with ischemic stroke. The investigators propose to develop a cli...
What is the current status of trial NCT04637087?
This trial is currently completed. It is a NA study. The enrollment target is 805 participants. The study started on 2021-03-11. Estimated completion is 2024-07-14.
What interventions are being tested in trial NCT04637087?
The interventions under investigation include: Atrial fibrillation risk electronic health record alert (OTHER).
Who is sponsoring clinical trial NCT04637087?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.